Design, synthesis, and physicochemical properties of a novel, conformationally restricted 2,3-dihydro-1,3,4-thiadiazole-containing angiotensin converting enzyme inhibitor which is preferentially eliminated by the biliary route in rats
Authors:
- Roger C. BrownRBRoger C. Brown
- Anthony R. CookACAnthony R. Cook
- Carol N. MannersCMCarol N. Manners
- David W. PaylingDPDavid W. Payling
- David H. RobinsonDRDavid H. Robinson
- 1 January 1991
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 34 (1) , 439-447